UTH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - United Therapeutics Corp

Watchlist Manager

Watchlist

Price: 427.4 EUR Market Closed

Market Cap: €12B

U	United Therapeutics Corp XBER:UTH	US
R	Reading International Inc NASDAQ:RDIB	US
S	Sandoz Group AG SIX:SDZ	CH
M	Murphy Oil Corp XMUN:MUQ	US
F	Francotyp Postalia Holding AG DUS:FPH	DE
B	Barclays PLC OTC:BCLYF	UK
	Grupo Aeroportuario del Centro Norte SAB de CV F:G7AB	MX
S	Serinus Energy PLC WSE:SEN	JE

Profitability Summary

United Therapeutics Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

87%

Strong 3Y Average Gross Margin

89%

Declining Gross Margin

91% > 87%

Exceptional Operating Margin

45%

Strong 3Y Average Operating Margin

49%

Declining Operating Margin

50% > 45%

Exceptional Net Margin

41%

Strong 3Y Average Net Margin

41%

Net Margin is Increasing

37% > 41%

Exceptional Free Cash Flow Margin

32%

Strong 3Y Average Free Cash Flow Margin

34%

Declining Free Cash Flow Margin

36% > 32%

Positive ROE

20%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

28%

ROIC is Increasing

25% > 28%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.